Free Trial

Accenture (NYSE:ACN) Given New $290.00 Price Target at JPMorgan Chase & Co.

Accenture logo with Computer and Technology background

Key Points

  • Accenture's price target has been lowered by JPMorgan Chase & Co. from $302 to $290, maintaining an "overweight" rating with a potential upside of 24.89% from the stock's previous close.
  • The company reported a quarterly EPS of $3.03, surpassing analysts' estimates, alongside a revenue of $17.60 billion, marking a 7.3% increase compared to the previous year.
  • Insider selling has been reported, with CEO Mauro Macchi and insider Angela Beatty both reducing their holdings in the company, reflecting recent movements among company executives.
  • MarketBeat previews the top five stocks to own by October 1st.

Accenture (NYSE:ACN - Get Free Report) had its price target decreased by stock analysts at JPMorgan Chase & Co. from $302.00 to $290.00 in a report issued on Friday,Benzinga reports. The firm presently has an "overweight" rating on the information technology services provider's stock. JPMorgan Chase & Co.'s price objective points to a potential upside of 24.89% from the stock's previous close.

ACN has been the subject of several other reports. Wolfe Research cut their price target on Accenture from $290.00 to $285.00 and set an "outperform" rating for the company in a report on Tuesday. Susquehanna reduced their target price on Accenture from $330.00 to $270.00 and set a "neutral" rating on the stock in a research report on Thursday, September 18th. Robert W. Baird decreased their price target on Accenture from $372.00 to $350.00 and set an "outperform" rating on the stock in a research note on Tuesday, September 16th. Barclays dropped their price objective on shares of Accenture from $390.00 to $360.00 and set an "overweight" rating for the company in a research note on Monday, June 23rd. Finally, Argus set a $370.00 target price on shares of Accenture in a research report on Tuesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Accenture currently has a consensus rating of "Moderate Buy" and an average price target of $321.33.

Check Out Our Latest Stock Analysis on ACN

Accenture Trading Down 2.9%

Shares of ACN stock opened at $232.20 on Friday. Accenture has a twelve month low of $229.40 and a twelve month high of $398.35. The company has a market capitalization of $145.43 billion, a price-to-earnings ratio of 18.49, a PEG ratio of 2.06 and a beta of 1.29. The firm has a 50-day moving average price of $254.28 and a 200 day moving average price of $286.89. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.16.

Accenture (NYSE:ACN - Get Free Report) last issued its quarterly earnings results on Thursday, September 25th. The information technology services provider reported $3.03 EPS for the quarter, topping analysts' consensus estimates of $2.98 by $0.05. The business had revenue of $17.60 billion during the quarter, compared to the consensus estimate of $17.34 billion. Accenture had a net margin of 11.61% and a return on equity of 26.55%. The company's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.66 earnings per share. Accenture has set its FY 2026 guidance at 13.190-13.570 EPS. Q1 2026 guidance at EPS. Research analysts forecast that Accenture will post 12.73 earnings per share for the current fiscal year.

Insider Buying and Selling at Accenture

In other Accenture news, insider Angela Beatty sold 203 shares of the business's stock in a transaction dated Friday, July 11th. The stock was sold at an average price of $282.34, for a total transaction of $57,315.02. Following the transaction, the insider owned 5,249 shares in the company, valued at $1,482,002.66. The trade was a 3.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Mauro Macchi sold 500 shares of the company's stock in a transaction dated Friday, July 11th. The stock was sold at an average price of $282.34, for a total value of $141,170.00. Following the completion of the sale, the chief executive officer directly owned 2,283 shares of the company's stock, valued at $644,582.22. The trade was a 17.97% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,954 shares of company stock valued at $834,280 over the last three months. 0.02% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ACN. Park Square Financial Group LLC acquired a new position in Accenture in the 4th quarter worth $31,000. Kelly Lawrence W & Associates Inc. CA acquired a new position in shares of Accenture in the first quarter worth about $31,000. Inlight Wealth Management LLC purchased a new position in Accenture in the first quarter valued at about $32,000. RMG Wealth Management LLC acquired a new stake in Accenture during the 2nd quarter valued at approximately $33,000. Finally, Howard Hughes Medical Institute purchased a new stake in Accenture during the 2nd quarter worth approximately $40,000. 75.14% of the stock is owned by institutional investors and hedge funds.

About Accenture

(Get Free Report)

Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.

Read More

Analyst Recommendations for Accenture (NYSE:ACN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Accenture Right Now?

Before you consider Accenture, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Accenture wasn't on the list.

While Accenture currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.